News

"Optimizing tumor treating fields for blood cancer therapy: Analysis of electric field distribution and dose density" by Nasori Nasori, Miftakhul Firdhaus, Ulya Farahdina, Rini Khamimatul Ula is published in BPPB as the J-STAGE Advance Publication.

2024 April 18 BPPB

A following article is published as the J-STAGE Advance Publication in "Biophysics and Physicobiology".

Nasori Nasori, Miftakhul Firdhaus, Ulya Farahdina, Rini Khamimatul Ula
"Optimizing tumor treating fields for blood cancer therapy: Analysis of electric field distribution and dose density"

URL:https://doi.org/10.2142/biophysico.bppb-v21.0013


Large Image

Abstract
Blood cancer is a condition in which white blood cells grow uncontrollably. Tumor treating fields (TTF) are a modality of cancer treatment that utilizes electric fields to target malignant cells. To optimize the efficacy of TTF, it is necessary to investigate the distribution of electric field through varying electrode configurations and input parameters. This allows for enhancement of electric field intensity in targeted areas while minimizing intensity in sensitive areas. Analysis of electric field distribution was conducted through simulation of brachial models with varying electrode configurations and input parameters, utilizing the COMSOL Multiphysics 5.4 software. Additionally, investigations were carried out to assess tissue dose density. The dose density value at primary target for all electrode configurations and input parameters do not exceed the threshold value (770 W/m3), whereas the electric field value at the primary target satisfied the threshold value (100 V/m) on the system that used 4 plate-shaped electrodes and arm contour-shaped electrodes with an input voltage of 20 V, and at the input voltage 15 V, only 4 arm contour-shaped electrodes that satisfied the threshold value. An increase in input voltage, electrodes addition, and electrodes adjustment to skin contour shape result in an enhancement of electric field distribution and average electric field value at primary targets.



Back to previous page